Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Total raised
$5.4M
1 round on record
Latest round
$5.4M
Seed · Sep 2026 · this month
Team
51-200
employees, estimated range
The money's age
Fresh money
0 months since the last round · not hiring
Momentum
20/100
fresh money
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Sep 24 Raised a round Seed $5.4M
Funding rounds
RoundDateAmountInvestorsSource
Seed Sep 2026 $5.4M — biopole.ch
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
okomeraFounded 2020
Okomera turns tumor response into treatment decisions. Its proprietary platform acts as a decentralized lab for clinicians and biopharma…
Solid IOFounded 2025 • 11-50 employees
Solid IO is transforming precision oncology with organ-on-chip technology, delivering real-time, patient-specific insights to improve…
ValarlabsVenture round $4.1M · 4 yr ago • Founded 2021 • 11-50 employees
Valar Labs makes diagnostics that use AI to interpret solid tumors and deliver insights, so physicians and patients can make informed…
Vesynta Ltd logoVenture round · 2 yr ago • 1-10 employees
Meet Vesynta, the UK team behind DosoLogic and PMX.Community, building a model-informed precision dosing ecosystem for safer, personalised…
GenomateConvertible Note $2M · 19 mo ago • Founded 2022 • 51-200 employees
Genomate helps physicians find the right targeted therapy for every cancer patient based on the individual molecular profile of their…
Theremia integrates patient and drug pharmacological characteristics to transform how treatments are developed and prescribed.

Overview

By testing the response of a patient’s own cancer cells against many treatment options, we help physicians and patients make truly informed personalized treatment decisions.

Financials

Total raised
$5.4M
Latest round
Seed
Funding rounds
1
Funding rounds
Round Announced Amount
Seed 2026 $5.4M Details